Oruka Therapeutics annual asset turnover
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2025
Oruka Therapeutics Asset Turnover Growth & History (ORKA)
Oruka Therapeutics's asset turnover was 0.00 for fiscal 2025.
View full Oruka Therapeutics company overviewOruka Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | — | — |
| 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| 2022 | 2022-12-31 | 0.00 | 0.00 | — |
| 2021 | 2021-12-31 | 0.00 | 0.00 | — |
| 2020 | 2020-12-31 | 0.00 | 0.00 | — |
| 2019 | 2019-12-31 | 0.00 | 0.00 | — |
| 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| 2017 | 2017-12-31 | 0.00 | 0.00 | — |
| 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| 2015 | 2015-12-31 | 0.00 | 0.00 | — |
| 2014 | 2014-12-31 | 0.00 | — | — |
Oruka Therapeutics quarterly asset turnover
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.00 | — | — |
| Q1 2026 | 2026-03-31 | 0.00 | — | — |
| Q4 2025 | 2025-12-31 | 0.00 | — | — |
| Q2 2024 | 2024-06-30 | 0.00 | 0.00 | — |
| Q1 2024 | 2024-03-31 | 0.00 | 0.00 | — |
| Q4 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| Q3 2023 | 2023-09-30 | 0.00 | 0.00 | — |
| Q2 2023 | 2023-06-30 | 0.00 | 0.00 | — |
| Q1 2023 | 2023-03-31 | 0.00 | 0.00 | — |
| Q4 2022 | 2022-12-31 | 0.00 | 0.00 | — |
| Q3 2022 | 2022-09-30 | 0.00 | 0.00 | — |
| Q2 2022 | 2022-06-30 | 0.00 | 0.00 | — |
| Q1 2022 | 2022-03-31 | 0.00 | 0.00 | — |
| Q4 2021 | 2021-12-31 | 0.00 | 0.00 | — |
| Q3 2021 | 2021-09-30 | 0.00 | 0.00 | — |
| Q2 2021 | 2021-06-30 | 0.00 | 0.00 | — |
| Q1 2021 | 2021-03-31 | 0.00 | 0.00 | — |
| Q4 2020 | 2020-12-31 | 0.00 | 0.00 | — |
| Q3 2020 | 2020-09-30 | 0.00 | 0.00 | — |
| Q2 2020 | 2020-06-30 | 0.00 | 0.00 | — |
| Q1 2020 | 2020-03-31 | 0.00 | 0.00 | — |
| Q4 2019 | 2019-12-31 | 0.00 | 0.00 | — |
| Q3 2019 | 2019-09-30 | 0.00 | 0.00 | — |
| Q2 2019 | 2019-06-30 | 0.00 | 0.00 | — |
| Q1 2019 | 2019-03-31 | 0.00 | 0.00 | — |
| Q4 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| Q3 2018 | 2018-09-30 | 0.00 | 0.00 | — |
| Q2 2018 | 2018-06-30 | 0.00 | 0.00 | — |
| Q1 2018 | 2018-03-31 | 0.00 | 0.00 | — |
| Q4 2017 | 2017-12-31 | 0.00 | 0.00 | — |
| Q3 2017 | 2017-09-30 | 0.00 | 0.00 | — |
| Q2 2017 | 2017-06-30 | 0.00 | 0.00 | — |
| Q1 2017 | 2017-03-31 | 0.00 | 0.00 | — |
| Q4 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| Q3 2016 | 2016-09-30 | 0.00 | — | — |
| Q2 2016 | 2016-06-30 | 0.00 | — | — |
| Q1 2016 | 2016-03-31 | 0.00 | — | — |
| Q4 2015 | 2015-12-31 | 0.00 | — | — |
Oruka Therapeutics asset turnover trends
Over the last five fiscal years, Oruka Therapeutics's asset turnover increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q2 2026, shows 0.00.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oruka Therapeutics source filings ↗Community posts
Oruka’s psoriasis study supports planned Phase 3 trials after strong skin clearance
Oruka ($ORKA) reported positive 16-week results for ORKA-001 in the randomized Phase 2b EVERLAST-B psoriasis study. Among 46 patients assigned the highest dose, 61% achieved complete skin clearance, compared with none of 47 placebo recipien ...
